“…Their low mechanical stability is also not adequate to support cells, and their products are thus insufficient for the regeneration of tissue. Moreover, the methods for obtaining such materials are limited due to the low resistance of natural polymers to changes in process parameters, such as high temperatures [ 25 , 50 , 51 , 57 , 59 , 64 , 76 , 86 ].Synthetic polymers, such as poly(ethylene glycol) (PEG) [ 87 , 88 ], polycaprolactone (PCL) [ 89 , 90 ], polylactic acid (PLA) [ 87 , 91 , 92 ], polyurethane [ 93 , 94 ], poly(glycolic acid) (PGA) [ 87 , 95 ], polyethersulfone (PES) [ 96 , 97 , 98 , 99 ], and polysulfone [ 100 , 101 ], are more diverse and promising. Some of these materials have been approved by the FDA for clinical human use [ 49 , 51 , 57 , 102 , 103 , 104 , 105 ].…”